New tests could spot nerve damage earlier in rare disease
NCT ID NCT05311488
Summary
This study aimed to find the best tools for detecting early nerve damage in people with hereditary transthyretin amyloidosis (TTRv), a rare disease. Researchers compared several methods, including a special skin microscope and a blood test, in 47 participants (both patients and healthy volunteers). The goal is to help doctors identify nerve problems sooner so treatment can start earlier to potentially slow the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.